0
Preliminary Program
Preliminary Program: Wednesday, May 23
Psychiatric News
Volume 42 Number 4 page 37-41
+

CME Courses 76-82

+

CME Courses 83-87

+

+

Component Workshops

CW37. Career Advancement in Administrative Psychiatry for Early Career PsychiatristsAPA Assembly Committee of Early Career Psychiatrists; Chair: Dimitri D. Markov, M.D.

CW38. The Sacred Herb and Addiction Science: A Study of Nicotine Dependence and Axis I Comorbidities Among American IndiansAPA Committee of American Indian, Alaska Native, and Native Hawaiian Psychiatrists; Chair: Daniel L. Dickerson, D.O.

CW39. Transcultural Arab Psychiatry With a Focus on Women's Mental HealthAPA Arab American Psychiatric Association; Chair: Ossama T. Osman, M.D.

CW40. Suicide Icon: The Golden Gate BridgeAPA Northern California Psychiatric Society; Chair: Mel Blaustein, M.D.

CW41. Lessons Learned From Business Practices: How Can Psychiatrists Increase Their Practice Opportunities by Implementing Successful Business StrategiesAPA Committee on APA/Business Relations; Chair: Gabriela Cora-Locatelli, M.D.

CW42. Social Dimensions of Disasters and Community RecoveryAPA Committee on Psychiatric Dimensions of Disasters; Chair: Jacqueline Henschke, M.D.

CW43. The Isms: How Racism, Sexism, Classism, and Heterosexism Affect Mental Health CareAPA/SAMHSA Minority Fellows; Chair: Karen R. Liaw, M.D.

CW44. Managed Care, Psychiatrists, and Employers: Collaborating Effectively to Ensure Patient CareAPA Committee on Managed Care; Chair: Paul Henry Wick, M.D.

CW45. Racism, Racial Discrimination, and Xenophobia: How Psychiatry Can Reduce Their Adverse Effects on Mental HealthAPA Council on Minority Mental Health and Health Disparities; Chair: Francis G. Lu, M.D.

+

Issue Workshops

IW51. Biopsychosocial and Spiritual Aspects of Treating Our Physician ColleaguesChair: Syed S. A. Naqvi, M.D.

IW52. Responding to the Impact of Suicide on CliniciansChair: Eric M. Plakun, M.D.

IW53. Developing Research Training Opportunities Within a Psychiatric Residency Training Program: Goals, Motivations, Barriers, and SolutionsChair: Robert J. Love, D.O.

IW54. The ADHD/Pediatric Bipolar Interface: Sailing Through Troubled Waters?Chair: Vishal Madaan, M.D.

IW55. Oral Boards Boot Camp: 2007Chair: Elyse D. Weiner, M.D.

IW56. Neuroimaging Research: Implications for the Treatment of Substance AbuseNational Institute on Drug Abuse; Chair: Steven J. Grant, Ph.D.

IW57. Project Match: A Resident Curriculum of Mentorship, Advocacy, Teaching, Career Issues, and HealthChair: Heather L. Flett, M.D.

IW58. The Resident Experiences a Patient Suicide: Strategies That Can HelpChair: Joan M. Anzia, M.D.

IW59. Telepsychiatry in Action: Implementing and Sustaining a Successful Telepsychiatry ProgramChair: Amir A. Khan, M.D.

IW60. Research Training for All Psychiatric Residents: A Problematic EndeavorChair: Milton Kramer, M.D.

IW61. Detecting Bipolar DisorderChair: Gary E. Miller, M.D.

IW62. Can We Do Better at Preventing the Chronic Course of Mood Disorders?Chair: Alina Marin, M.D.

IW63. Safety Training for Medical Students During Their Psychiatry ClerkshipChair: Erica Z. Shoemaker, M.D.

IW64. The Role ofDSM-IVRating Scales in PsychiatryChair: Joyce Sprafkin, Ph.D.

+

Lectures

L20.Lawrence Hartmann, M.D., APA's John Fryer Award Lecture

+

+

Media Workshops

MP5. Rock Bottom: Understanding the Methamphetamine Experience and the Struggle for SobrietyChair: Steven J. Lee, M.D.

MP6. "We Are Dad": HIV-Positive Children and Lesbian, Gay, Bisexual, or Transgender ParentingChair: R. Kaan Ozbayrak, M.D.

MP7. Psychiatric Residents' Perspective of Couples and Family Therapy TrainingChair: Ian E. Alger, M.D.

+

+

Advances In

Advances in Geriatric PsychiatryDan Blazer, M.D.

+

+

Component Workshops

CW46. Leadership Challenges: Breaking Barriers to SuccessAPA Committeeon International Medical Graduates; Chair: Antony Fernandez, M.D.

CW47. Public Policy, HIV, and Mental Health: Politics, Ideology, or ScienceAPA New York County District Branch's AIDS Committee; Chair: Mary Ann Cohen, M.D.

CW48.CPTCoding and Documentation UpdateAPA Committee on RBRVS, Codes, and Reimbursements; Chair: Ronald M. Burd, M.D.

CW49. Ethics and Etiquette: Keeping Out of TroubleAPA Ethics Committee; Chair: Wade C. Myers, M.D.

CW50. Managing Opiate Detoxification With Buprenorphine/NaloxoneAPA Council on Addiction Psychiatry; Chair: John A. Renner Jr., M.D.

CW51. New APA Practice Guidelines on Dementia, Panic Disorder, and OCDAPA Steering Committee on Practice Guidelines; Chair: John S. McIntyre, M.D.

CW52. Mission Possible: Reclaiming America's State Hospital BedsAPA Council on Social Issues and Public Psychiatry; Chair: Tracee Burroughs, M.D.

CW53. Early Cognitive Development and Psychiatric Presentation: Implications for Etiologic Understanding and InterventionAPA Corresponding Committee on Infancy and Early Childhood; Chair: Jean M. Thomas, M.D.

CW54. Mentoring of Women in Academic PsychiatryAPA Central California Psychiatric Society; Chair: Linda L.M. Worley, M.D.

+

Issue Workshops

IW65. Complexities of Post-Termination RelationshipsChair: Malkah T. Notman, M.D.

IW66. Ethnicity, Culture, and Psychopharmacology: Recent AdvancesChair: Pedro Ruiz, M.D.

IW67. Cognitive-Behavior Therapy for Psychosis in Practice: Basic Techniques for PsychiatristsChair: Shanaya Rathod, M.D.

IW68. Promising Medications for the Treatment of Cocaine AddictionNational Institute on Drug Abuse; Chair: Ahmed Elkashef, M.D.

IW69. Psychiatrists Who Have Been in Treatment: An Interactive DiscussionChairs: Michael F. Myers, M.D., Leah J. Dickstein, M.D.

IW70. Electrifying Discourses: Presentation and Communication Skills for Psychiatrists and TraineesChair: Shyam K. Bhat, M.D.

IW71. Air Force Suicide Prevention Program: A Community and Organizational Approach to PreventionChair: Steven E. Pflanz, M.D.

IW72. Day-to-Day Variability in Bipolar DisorderChair: Jan L. Scott, M.D.

IW73. From the Mississippi to the Ganges: Understanding the Cross-Cultural Context of Treatment From the Perspective of the South-Asian Psychiatrist in AmericaIndo-American Psychiatric Association; Chair: Sudeepta Varma, M.D.

IW74. Religious and Spiritual Assessment in Clinical PracticeChair: Francis G. Lu, M.D.

IW75. From Evidence to Clinical Methods in Integrative Mental Health CareChair: James Lake, M.D.

IW76. Gay Men and Crystal Methamphetamine: A ReviewChair: Eugene Lee, M.D.

+

Lectures

L21.Nancy C. Andreasen, M.D., APA's Judd Marmor Award Lecture

L22.William T. Carpenter, M.D., Distinguished Psychiatrist Lecture Series

+

Scientific and Clinical Reports Session 19. Psychopharmacology and Schizophrenia

55.Number Needed to Treat and Number Needed to Harm: Making Sense of CATIE Leslie L. Citrome, M.D.

56. Switching From Long-Acting Typical Antipsycotic Drugs to the Second-Generation Antipsychotics Olanzapine and Risperidone in the Treatment of Chronic Schizophrenia Patients Marnina Swartz-Vanetik, M.D.

57. zolpidem in Treatment-Resistant Catatonia: Two Case Reports and Literature Review Cristinel M. Coconcea, M.D.

+

Session 20. Managing Violence

58. Variables Affecting Violence That Required Physical Restraint Among Psychiatric Inpatients During the First Week of Hospitalization Pinkhas Sirota, M.D.

59. Decreasing the Use of Restraint and Seclusion Among Psychiatric Inpatients David J. Hellerstein, M.D.

60. CES Reduces Aggression in Violent Neuropsychiatric Patients Allen Childs, M.D.

+

Session 21. Continuation and Discontinuation of SSRIs

61. Comparison of the Prophylactic Efficacy of Antidepressants—Factors Associated With Better Outcome Sabrina J. Khan, M.D.

62. How Often Do SSRIs Lose Their Effect During Continuation Treatment? Evidence Suggesting the Rate Is True Tachyphylaxis During Continuation Treatment Is Low Mark Zimmerman, M.D.

63. Discontinuation of SSRIs After Five years' Stability Tara M. Pundiak, M.D.

+

Session 22. Sex, Attraction, and Intimacy

64. An Eight-Week Randomized, Double-Blind, Placebo-Controlled Trial of PDE5I Sildenafil Treatment of SRI-Antidepressant-Associated Sexual Dysfunction in Women With Major Depression Disorder in Remission: Identifying a Hormone Endophenotype Associated With Treatment H. George Nurnberg, M.D.

65. Breakthrough Intimacy—Treating Personality Yukio Ishizuka, M.D.

66. A Link Between Oxytocin and Anxiety of Romantic Attachment Donatella Marazziti, M.D.

+

Session 23. Psychopharmacology and Bipolar Disorder

67. Effect of Comorbid Anxiety on Antidepressant Use in a Community Sample of Bipolar Subjects Ayal Schaffer, M.D.

68. Difficult-to-Treat Patients: The Role of Quetiapine in the Management of Acute Bipolar Depression (With a Focus on Bipolar II Patients) Michael E. Thase, M.D.

69. Indirect Comparison of the Safety and Tolerability of Antipsychotics in Patients With Bipolar Disorder and Schizophrenia Keming Gao, M.D.

+

Session 24. Treatment Issues in College and Medical Students

70. Subjective Sleep Quality and Suicidal Ideation Among College Students Shamsah B. Sonawalla, M.D.

71. Prevalence and Attitudes Concerning ADHD Diagnosis and Use of Stimulant Medications in Medical Students Jeffrey Tuttle, M.D.

72. Prevalence and Symptom Patterns of Depression Among College Students: Findings From a Cross-Cultural Study Across Boston and Bombay Rajesh M. Parikh, M.D.

+

Session 25. Functioning and Disease Burdens in Mood Disorders

73. Disease Burden of Bipolar and Schizoaffective Disorder in an Australian Cohort Jayashri Kulkarni, M.B.B.S.

74. Days Missed From Work in Patients With Major Depressive Disorder With or Without a Personality Disorder Daniela A. Boerescu, M.D.

75. The Relationship Between Global Functioning, Depression, and Painful Somatic Symptoms in Patients With Major Depressive Disorder Thomas N. Wise, M.D.

+

Session 26. Stigma and Discrimination

76. How Dangerous Is Stigma? Perceived Stigma and HIV Risk Among Women With Severe Mental Illness Pamela Y. Collins

77. Comparison of Public's Stigma Attitude Between Mental Illness and Physical Handicap Chih-Wei Yang, M.D.

78. Obsessions About Homosexuality and the y-BOCS—Lessons From an Antidiscrimination Case in Sweden Christian Rück, M.D.

+

Session 27. Suicide and Self-Destruction

79. The 10-year Course of Physically Self-Destructive Acts of Patients With Borderline Personality Disorder Mary C. Zanarini, Ed.D.

80. Indicators of Treatment-Refractory Illness and Risk of Suicide John W. Goethe, M.D.

81. Personality Traits as Prospective Predictors of Suicide Attempts: Negative Affectivity/Temperament and Disinhibition in a Personality Disorder Sample Shirley Yen, Ph.D.

+

CME Courses 88-91

+

+

Lectures

L23. Psychosis on the Streets: An Ethnography of Chicago's NetherworldTanya Luhrmann, Ph.D., Frontiers of Science Lecture Series

L24.Leah J. Dickstein, M.D., Distinguished Psychiatrist Lecture Series

+

+

Presidential Symposia

5. Health Inequalities for Persons With Mental Health Problems and Developmental DisabilitiesRoyal College of Psychiatrists; Chair: Sheila Hollins, M.B.

6. Focusing on European PsychiatryAPA Council on Global Psychiatry; Chair: Pedro Ruiz, M.D.

7. Globalization and Mental Health: Role of Spanish-Speaking PsychiatryChair: Renato D. Alarçon, M.D.

+

Symposia

S52. Behavioral and Substance Addictions in Minority Populations

S53. Treatment of Depression in the Medically Ill: An Update From Recent Clinical Trials

S54. Drug Abuse Treatment Within the Criminal Justice System: Addressing Our Nation's Public Health Needs

S55. Improving Cross-Cultural Competency in Psychiatric Practice

S56. Eating Behavior in Schizophrenia: Biological and Clinical Implications

S57. Simple Technologies to Improve Psychotherapy

S58. Psychiatric Training Across the Continents: International Young Psychiatrist Perspectives

S59. American Psychiatry Viewed From the Outside: A Global Perspective on theDSMsand Psychopharmacology

S60. The End, Middle, and Beginning of the Affair: Infidelity in Film and Television

S61. Connections to Medical Information

S62. Prescribing Patterns, Predictors, and Costs for Antidepressant Medications

S63. Neurobiology of the Unconscious: Implications for Psychotherapeutic Understanding and Technique

S64. Update on the Biology of Personality Disorders

S65. A Picture of the Development of the Adolescent Brain: A Structural and Functional Assessment

S66. An Update on Cross-Cultural, Ethnic, and Ethnopsychopharmacological Aspects of Mood Disorders

S67. Ethics of Treating Subsyndromal Psychiatric Disorders

S68. Innovations in the Treatment of Adolescent Substance Use Disorders

S69. Sexuality in Long-Term-Care Facility Residents

S70. The Sexually Violent Offender

S71. Prenatal Nicotine Exposure: How Does It Relate to Developmental Vulnerabilities?

S72. The IOM Informs, NAMI Storms, and AACP Transforms: How to Make the Grade in Response to the U.S. Mental Health System's Bad Report Card

S73. HIV Update for Psychiatric Care

S74. Dissociative Disorders: Meeting the Challenge ofDSM-V

+

+

Advances In

Advances in C-L Psychiatry and Psychosomatic MedicineJames L. Levenson, M.D.

+

+

Industry-Supported Symposium

IS32. Fibromyalgia: New Insights Into the Pathophysiology and TreatmentSupported by Pfizer Inc.

Interactive Graphics

Video

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Articles
Articles